The company has poor fundamentals for a short-term investment strategy.
Strengths
Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
The group usually releases upbeat results with huge surprise rates.
For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
One of the major weak points of the company is its financial situation.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 69.17 times its estimated earnings per share for the ongoing year.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
